CAR-T Cell Therapy – Frederick Locke, MD, and Robert Figlin, MD, discuss clinical highlights from ASH 2018 - a podcast by OBR Peer-Spectives

from 2018-12-18T21:42:58

:: ::

Robert Figlin, MD, Steven Spielberg Family Chair in Hematology-Oncology, Cedars-Sinai Medical Center and Frederick Locke, MD, Program Co-Leader, Immunology, Moffitt Cancer Center discuss CAR-T clinical highlights from ASH 2018

Further episodes of OBR Peer-Spectives

Further podcasts by OBR Peer-Spectives

Website of OBR Peer-Spectives